AbbVie (ABBV) Receives a Buy from Argus Research
Argus Research analyst Jasper Hellweg maintained a Buy rating on AbbVie (ABBV – Research Report) on January 31. The company’s shares opened ...
ABBV Earnings: AbbVie Rallies Alongside Q4 Beats
AbbVie (ABBV) stock rallied today after the biopharmaceutical company posted its Q4 2024 earnings report. The good news ...